Cagrilintide/semaglutide
A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity
Novo Nordisk · Phase 1 · Completed · Enrollment 40
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Part A: Cagrilintide and semaglutide in separate syringes | n/r | n/r | n/r | n/r |
| Part A: Cagrilintide and semaglutide combined in DV3384 device | n/r | n/r | n/r | n/r |
| Part B: Cagrilintide and semaglutide combined in DV3384 device | n/r | n/r | n/r | n/r |
Not shown
- Part A: Cagrilintide and semaglutide in separate syringes: endpoint not reported
- Part A: Cagrilintide and semaglutide combined in DV3384 device: endpoint not reported
- Part B: Cagrilintide and semaglutide combined in DV3384 device: endpoint not reported